IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gilead Sciences, Inc.

Q4 2024 Holdings

Filed 2025-02-13 | 16 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcellx Inc(ACLX)COMMON STOCK03940C100$515.4M6,720,80333.2%
Galapagos NV(GLPG)SPON ADR36315X101$461.7M16,707,47729.8%
Arcus Biosciences Inc(RCUS)COM03969F109$447.6M30,061,12428.9%
Assembly Biosciences Inc(ASMB)COM NEW045396207$34.9M2,209,4712.2%
Merus N VCOMN5749R100$19.0M452,5271.2%
Kyverna Therapeutics Inc(KYTX)COM501976104$15.4M4,126,1191.0%
Leap Therapeutics Inc(CYPH)COM NEW52187K200$15.3M5,319,1481.0%
Tango Therapeutics Inc(TNGX)COM87583X109$15.0M4,854,4431.0%
Xilio Therapeutics Inc(XLO)COM98422T100$8.7M9,105,4510.6%
Allovir IncCOM019818103$7.0M16,635,2860.5%
Hookipa Pharma Inc(HOOK)COM NEW43906K209$3.8M1,875,9450.2%
Ikena Oncology IncCOM45175G108$3.3M2,008,3380.2%
Allogene Therapeutics Inc(ALLO)COM019770106$2.5M1,156,6890.2%
Barinthus Biotherapeutics PL(BRNS)ADS91864C107$749.4K620,3510.0%
Agenus Inc(AGEN)COM NEW00847G804$634.8K231,6630.0%
Kronos BIO Inc(KRON1USD)COM50107A104$179.1K188,5670.0%